Combination chemotherapy followed by an immunotoxin (anti-B4-blocked ricin) in patients with indolent lymphoma: results of a phase II study. [electronic resource]
Producer: 20001026Description: 146-50 p. digitalISSN:- 1528-9117
- Adult
- Aged
- Antineoplastic Agents -- therapeutic use
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Bleomycin -- therapeutic use
- Cyclophosphamide -- therapeutic use
- Cytarabine -- therapeutic use
- Disease-Free Survival
- Doxorubicin -- therapeutic use
- Etoposide -- therapeutic use
- Female
- Humans
- Immunoconjugates -- therapeutic use
- Immunotoxins -- therapeutic use
- Leukemia, Lymphocytic, Chronic, B-Cell -- drug therapy
- Lymphoma -- drug therapy
- Lymphoma, Follicular -- drug therapy
- Lymphoma, Mantle-Cell -- drug therapy
- Male
- Methotrexate -- therapeutic use
- Middle Aged
- Prednisone -- therapeutic use
- Ricin -- therapeutic use
- Time Factors
- Treatment Outcome
- Vincristine -- therapeutic use
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article
There are no comments on this title.
Log in to your account to post a comment.